Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 193 to 203 of 203 entries
Sorted by: Best Match Show Resources per page
Expanding the clinical phenotype in patients with disease causing variants associated with atypical Usher syndrome.

Ophthalmic genetics

Igelman AD, Ku C, da Palma MM, Georgiou M, Schiff ER, Lam BL, Sankila EM, Ahn J, Pyers L, Vincent A, Ferraz Sallum JM, Zein WM, Oh JK, Maldonado RS, Ryu J, Tsang SH, Gorin MB, Webster AR, Michaelides M, Yang P, Pennesi ME.
PMID: 34223797
Ophthalmic Genet. 2021 Dec;42(6):664-673. doi: 10.1080/13816810.2021.1946704. Epub 2021 Jul 05.

Atypical Usher syndrome (USH) is poorly defined with a broad clinical spectrum. Here, we characterize the clinical phenotype of disease caused by variants in

Cite
Igelman AD, Ku C, da Palma MM, et al. Expanding the clinical phenotype in patients with disease causing variants associated with atypical Usher syndrome. Ophthalmic Genet. 2021;42(6):664-673doi: 10.1080/13816810.2021.1946704.
Igelman, A. D., Ku, C., da Palma, M. M., Georgiou, M., Schiff, E. R., Lam, B. L., Sankila, E. M., Ahn, J., Pyers, L., Vincent, A., Ferraz Sallum, J. M., Zein, W. M., Oh, J. K., Maldonado, R. S., Ryu, J., Tsang, S. H., Gorin, M. B., Webster, A. R., Michaelides, M., Yang, P., & Pennesi, M. E. (2021). Expanding the clinical phenotype in patients with disease causing variants associated with atypical Usher syndrome. Ophthalmic genetics, 42(6), 664-673. https://doi.org/10.1080/13816810.2021.1946704
Igelman, Austin D, et al. "Expanding the clinical phenotype in patients with disease causing variants associated with atypical Usher syndrome." Ophthalmic genetics vol. 42,6 (2021): 664-673. doi: https://doi.org/10.1080/13816810.2021.1946704
Igelman AD, Ku C, da Palma MM, Georgiou M, Schiff ER, Lam BL, Sankila EM, Ahn J, Pyers L, Vincent A, Ferraz Sallum JM, Zein WM, Oh JK, Maldonado RS, Ryu J, Tsang SH, Gorin MB, Webster AR, Michaelides M, Yang P, Pennesi ME. Expanding the clinical phenotype in patients with disease causing variants associated with atypical Usher syndrome. Ophthalmic Genet. 2021 Dec;42(6):664-673. doi: 10.1080/13816810.2021.1946704. Epub 2021 Jul 05. PMID: 34223797.
Copy Download .nbib Format: NLM
Clinical and demographic correlates of accelerometer-measured physical activity in participants enrolled in the OPTIMISE HFpEF study.

European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology

Lin H, Hartley P, Forsyth F, Pilling M, Hobbs FDR, Taylor CJ, Schiff R, Deaton C.
PMID: 33837414
Eur J Cardiovasc Nurs. 2022 Jan 11;21(1):67-75. doi: 10.1093/eurjcn/zvab028.

AIMS: This study aimed to measure physical activity (PA) in participants with suspected heart failure with preserved ejection fraction (HFpEF) and assess associations between PA and participant characteristics.METHODS AND RESULTS: Adults with presumed HFpEF were recruited and received diagnostic...

Cite
Lin H, Hartley P, Forsyth F, et al. Clinical and demographic correlates of accelerometer-measured physical activity in participants enrolled in the OPTIMISE HFpEF study. Eur J Cardiovasc Nurs. 2022;21(1):67-75doi: 10.1093/eurjcn/zvab028.
Lin, H., Hartley, P., Forsyth, F., Pilling, M., Hobbs, F. D. R., Taylor, C. J., Schiff, R., & Deaton, C. (2022). Clinical and demographic correlates of accelerometer-measured physical activity in participants enrolled in the OPTIMISE HFpEF study. European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology, 21(1), 67-75. https://doi.org/10.1093/eurjcn/zvab028
Lin, Helen, et al. "Clinical and demographic correlates of accelerometer-measured physical activity in participants enrolled in the OPTIMISE HFpEF study." European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology vol. 21,1 (2022): 67-75. doi: https://doi.org/10.1093/eurjcn/zvab028
Lin H, Hartley P, Forsyth F, Pilling M, Hobbs FDR, Taylor CJ, Schiff R, Deaton C. Clinical and demographic correlates of accelerometer-measured physical activity in participants enrolled in the OPTIMISE HFpEF study. Eur J Cardiovasc Nurs. 2022 Jan 11;21(1):67-75. doi: 10.1093/eurjcn/zvab028. PMID: 33837414.
Copy Download .nbib Format: NLM
Caring for Families Impacted by Opioid Use: A Qualitative Analysis of Integrated Program Designs.

Academic pediatrics

Schiff DM, Partridge S, Gummadi NH, Gray JR, Stulac S, Costello E, Wachman EM, Jones HE, Greenfield SF, Taveras EM, Bernstein JA.
PMID: 33901729
Acad Pediatr. 2022 Jan-Feb;22(1):125-136. doi: 10.1016/j.acap.2021.04.016. Epub 2021 Apr 24.

OBJECTIVE: We sought to 1) identify models of integrated care that offer medical care and social services for children and families impacted by opioid use disorder (OUD) in the postpartum year; and 2) describe how each program was developed,...

Cite
Schiff DM, Partridge S, Gummadi NH, et al. Caring for Families Impacted by Opioid Use: A Qualitative Analysis of Integrated Program Designs. Acad Pediatr. 2021;22(1):125-136doi: 10.1016/j.acap.2021.04.016.
Schiff, D. M., Partridge, S., Gummadi, N. H., Gray, J. R., Stulac, S., Costello, E., Wachman, E. M., Jones, H. E., Greenfield, S. F., Taveras, E. M., & Bernstein, J. A. (2022). Caring for Families Impacted by Opioid Use: A Qualitative Analysis of Integrated Program Designs. Academic pediatrics, 22(1), 125-136. https://doi.org/10.1016/j.acap.2021.04.016
Schiff, Davida M, et al. "Caring for Families Impacted by Opioid Use: A Qualitative Analysis of Integrated Program Designs." Academic pediatrics vol. 22,1 (2022): 125-136. doi: https://doi.org/10.1016/j.acap.2021.04.016
Schiff DM, Partridge S, Gummadi NH, Gray JR, Stulac S, Costello E, Wachman EM, Jones HE, Greenfield SF, Taveras EM, Bernstein JA. Caring for Families Impacted by Opioid Use: A Qualitative Analysis of Integrated Program Designs. Acad Pediatr. 2022 Jan-Feb;22(1):125-136. doi: 10.1016/j.acap.2021.04.016. Epub 2021 Apr 24. PMID: 33901729; PMCID: PMC8542059.
Copy Download .nbib Format: NLM
Latent Class Analysis of Prescribing Behavior of Primary Care Physicians in the Veterans Health Administration.

Journal of general internal medicine

Barrett AK, Cashy JP, Thorpe CT, Hale JA, Suh K, Lambert BL, Galanter W, Linder JA, Schiff GD, Gellad WF.
PMID: 34993865
J Gen Intern Med. 2022 Jan 06; doi: 10.1007/s11606-021-07248-9. Epub 2022 Jan 06.

BACKGROUND: Benzodiazepines, opioids, proton-pump inhibitors (PPIs), and antibiotics are frequently prescribed inappropriately by primary care physicians (PCPs), without sufficient consideration of alternative options or adverse effects. We hypothesized that distinct groups of PCPs could be identified based on their...

Cite
Barrett AK, Cashy JP, Thorpe CT, et al. Latent Class Analysis of Prescribing Behavior of Primary Care Physicians in the Veterans Health Administration. J Gen Intern Med. 2022;doi: 10.1007/s11606-021-07248-9.
Barrett, A. K., Cashy, J. P., Thorpe, C. T., Hale, J. A., Suh, K., Lambert, B. L., Galanter, W., Linder, J. A., Schiff, G. D., & Gellad, W. F. (2022). Latent Class Analysis of Prescribing Behavior of Primary Care Physicians in the Veterans Health Administration. Journal of general internal medicine, . https://doi.org/10.1007/s11606-021-07248-9
Barrett, Alexis K, et al. "Latent Class Analysis of Prescribing Behavior of Primary Care Physicians in the Veterans Health Administration." Journal of general internal medicine vol. (2022). doi: https://doi.org/10.1007/s11606-021-07248-9
Barrett AK, Cashy JP, Thorpe CT, Hale JA, Suh K, Lambert BL, Galanter W, Linder JA, Schiff GD, Gellad WF. Latent Class Analysis of Prescribing Behavior of Primary Care Physicians in the Veterans Health Administration. J Gen Intern Med. 2022 Jan 06; doi: 10.1007/s11606-021-07248-9. Epub 2022 Jan 06. PMID: 34993865.
Copy Download .nbib Format: NLM
Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research

De Angelis C, Fu X, Cataldo ML, Nardone A, Pereira R, Veeraraghavan J, Nanda S, Qin L, Sethunath V, Wang T, Hilsenbeck SG, Benelli M, Migliaccio I, Guarducci C, Malorni L, Litchfield LM, Liu J, Donaldson J, Selenica P, Brown DN, Weigelt B, Reis-Filho JS, Park BH, Hurvitz SA, Slamon DJ, Rimawi MF, Jansen VM, Jeselsohn R, Osborne CK, Schiff R.
PMID: 33536276
Clin Cancer Res. 2021 Sep 01;27(17):4870-4882. doi: 10.1158/1078-0432.CCR-19-4191. Epub 2021 Feb 03.

PURPOSE: Cyclin-dependent kinase 4 (CDK4) and CDK6 inhibitors (CDK4/6i) are highly effective against estrogen receptor-positive (EREXPERIMENTAL DESIGN: Parental breast cancer cells and their endocrine-resistant derivatives (EndoR) were used. Derivatives with acquired resistance to palbociclib (PalboR) were generated from parental...

Cite
De Angelis C, Fu X, Cataldo ML, et al. Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer. Clin Cancer Res. 2021;27(17):4870-4882doi: 10.1158/1078-0432.CCR-19-4191.
De Angelis, C., Fu, X., Cataldo, M. L., Nardone, A., Pereira, R., Veeraraghavan, J., Nanda, S., Qin, L., Sethunath, V., Wang, T., Hilsenbeck, S. G., Benelli, M., Migliaccio, I., Guarducci, C., Malorni, L., Litchfield, L. M., Liu, J., Donaldson, J., Selenica, P., Brown, D. N., Weigelt, B., Reis-Filho, J. S., Park, B. H., Hurvitz, S. A., Slamon, D. J., Rimawi, M. F., Jansen, V. M., Jeselsohn, R., Osborne, C. K., & Schiff, R. (2021). Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(17), 4870-4882. https://doi.org/10.1158/1078-0432.CCR-19-4191
De Angelis, Carmine, et al. "Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,17 (2021): 4870-4882. doi: https://doi.org/10.1158/1078-0432.CCR-19-4191
De Angelis C, Fu X, Cataldo ML, Nardone A, Pereira R, Veeraraghavan J, Nanda S, Qin L, Sethunath V, Wang T, Hilsenbeck SG, Benelli M, Migliaccio I, Guarducci C, Malorni L, Litchfield LM, Liu J, Donaldson J, Selenica P, Brown DN, Weigelt B, Reis-Filho JS, Park BH, Hurvitz SA, Slamon DJ, Rimawi MF, Jansen VM, Jeselsohn R, Osborne CK, Schiff R. Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer. Clin Cancer Res. 2021 Sep 01;27(17):4870-4882. doi: 10.1158/1078-0432.CCR-19-4191. Epub 2021 Feb 03. PMID: 33536276; PMCID: PMC8628647.
Copy Download .nbib Format: NLM
Restoring order at the cell cycle border: Co-targeting CDK4/6 and CDK2.

Cancer cell

Jeselsohn R, Schiff R, Grinshpun A.
PMID: 34506738
Cancer Cell. 2021 Oct 11;39(10):1302-1305. doi: 10.1016/j.ccell.2021.08.007. Epub 2021 Sep 09.

Overcoming resistance to CDK4/6 inhibitors is a major clinical challenge. In this issue of Cancer Cell, Freeman-Cook et al. study mechanisms of resistance to CDK4/6 inhibitors by employing a CRISPRa screen. They identify the cyclin E-CDK2 axis and Myc...

Cite
Jeselsohn R, Schiff R, Grinshpun A. Restoring order at the cell cycle border: Co-targeting CDK4/6 and CDK2. Cancer Cell. 2021;39(10):1302-1305doi: 10.1016/j.ccell.2021.08.007.
Jeselsohn, R., Schiff, R., & Grinshpun, A. (2021). Restoring order at the cell cycle border: Co-targeting CDK4/6 and CDK2. Cancer cell, 39(10), 1302-1305. https://doi.org/10.1016/j.ccell.2021.08.007
Jeselsohn, Rinath, et al. "Restoring order at the cell cycle border: Co-targeting CDK4/6 and CDK2." Cancer cell vol. 39,10 (2021): 1302-1305. doi: https://doi.org/10.1016/j.ccell.2021.08.007
Jeselsohn R, Schiff R, Grinshpun A. Restoring order at the cell cycle border: Co-targeting CDK4/6 and CDK2. Cancer Cell. 2021 Oct 11;39(10):1302-1305. doi: 10.1016/j.ccell.2021.08.007. Epub 2021 Sep 09. PMID: 34506738.
Copy Download .nbib Format: NLM
Interferon Signaling in Estrogen Receptor-positive Breast Cancer: A Revitalized Topic.

Endocrinology

Fu X, De Angelis C, Schiff R.
PMID: 34791151
Endocrinology. 2022 Jan 01;163(1). doi: 10.1210/endocr/bqab235.

Cancer immunology is the most rapidly expanding field in cancer research, with the importance of immunity in cancer pathogenesis now well accepted including in the endocrine-related cancers. The immune system plays an essential role in the development of ductal...

Cite
Fu X, De Angelis C, Schiff R. Interferon Signaling in Estrogen Receptor-positive Breast Cancer: A Revitalized Topic. Endocrinology. 2022;163(1)doi: 10.1210/endocr/bqab235.
Fu, X., De Angelis, C., & Schiff, R. (2022). Interferon Signaling in Estrogen Receptor-positive Breast Cancer: A Revitalized Topic. Endocrinology, 163(1), . https://doi.org/10.1210/endocr/bqab235
Fu, Xiaoyong, et al. "Interferon Signaling in Estrogen Receptor-positive Breast Cancer: A Revitalized Topic." Endocrinology vol. 163,1 (2022). doi: https://doi.org/10.1210/endocr/bqab235
Fu X, De Angelis C, Schiff R. Interferon Signaling in Estrogen Receptor-positive Breast Cancer: A Revitalized Topic. Endocrinology. 2022 Jan 01;163(1). doi: 10.1210/endocr/bqab235. PMID: 34791151.
Copy Download .nbib Format: NLM
Is comprehensive geriatric assessment hospital at home a cost-effective alternative to hospital admission for older people?.

Age and ageing

Singh S, Gray A, Shepperd S, Stott DJ, Ellis G, Hemsley A, Khanna P, Ramsay S, Schiff R, Tsiachristas A, Wilkinson A, Young J.
PMID: 34969074
Age Ageing. 2021 Dec 31; doi: 10.1093/ageing/afab220. Epub 2021 Dec 31.

BACKGROUND: hospital level healthcare in the home guided by comprehensive geriatric assessment (CGA) might provide a less costly alternative to hospitalisation for older people.OBJECTIVE: to determine the cost-effectiveness of CGA admission avoidance hospital at home (HAH) compared with hospital...

Cite
Singh S, Gray A, Shepperd S, et al. Is comprehensive geriatric assessment hospital at home a cost-effective alternative to hospital admission for older people?. Age Ageing. 2021;doi: 10.1093/ageing/afab220.
Singh, S., Gray, A., Shepperd, S., Stott, D. J., Ellis, G., Hemsley, A., Khanna, P., Ramsay, S., Schiff, R., Tsiachristas, A., Wilkinson, A., & Young, J. (2021). Is comprehensive geriatric assessment hospital at home a cost-effective alternative to hospital admission for older people?. Age and ageing, . https://doi.org/10.1093/ageing/afab220
Singh, Surya, et al. "Is comprehensive geriatric assessment hospital at home a cost-effective alternative to hospital admission for older people?." Age and ageing vol. (2021). doi: https://doi.org/10.1093/ageing/afab220
Singh S, Gray A, Shepperd S, Stott DJ, Ellis G, Hemsley A, Khanna P, Ramsay S, Schiff R, Tsiachristas A, Wilkinson A, Young J. Is comprehensive geriatric assessment hospital at home a cost-effective alternative to hospital admission for older people?. Age Ageing. 2021 Dec 31; doi: 10.1093/ageing/afab220. Epub 2021 Dec 31. PMID: 34969074.
Copy Download .nbib Format: NLM
Is comprehensive geriatric assessment hospital at home a cost-effective alternative to hospital admission for older people?.

Age and ageing

Singh S, Gray A, Shepperd S, Stott DJ, Ellis G, Hemsley A, Khanna P, Ramsay S, Schiff R, Tsiachristas A, Wilkinson A, Young J.
PMID: 34969074
Age Ageing. 2022 Jan 06;51(1). doi: 10.1093/ageing/afab220.

BACKGROUND: hospital level healthcare in the home guided by comprehensive geriatric assessment (CGA) might provide a less costly alternative to hospitalisation for older people.OBJECTIVE: to determine the cost-effectiveness of CGA admission avoidance hospital at home (HAH) compared with hospital...

Cite
Singh S, Gray A, Shepperd S, et al. Is comprehensive geriatric assessment hospital at home a cost-effective alternative to hospital admission for older people?. Age Ageing. 2022;51(1)doi: 10.1093/ageing/afab220.
Singh, S., Gray, A., Shepperd, S., Stott, D. J., Ellis, G., Hemsley, A., Khanna, P., Ramsay, S., Schiff, R., Tsiachristas, A., Wilkinson, A., & Young, J. (2022). Is comprehensive geriatric assessment hospital at home a cost-effective alternative to hospital admission for older people?. Age and ageing, 51(1), . https://doi.org/10.1093/ageing/afab220
Singh, Surya, et al. "Is comprehensive geriatric assessment hospital at home a cost-effective alternative to hospital admission for older people?." Age and ageing vol. 51,1 (2022). doi: https://doi.org/10.1093/ageing/afab220
Singh S, Gray A, Shepperd S, Stott DJ, Ellis G, Hemsley A, Khanna P, Ramsay S, Schiff R, Tsiachristas A, Wilkinson A, Young J. Is comprehensive geriatric assessment hospital at home a cost-effective alternative to hospital admission for older people?. Age Ageing. 2022 Jan 06;51(1). doi: 10.1093/ageing/afab220. PMID: 34969074; PMCID: PMC8753046.
Copy Download .nbib Format: NLM
Fecal SARS-CoV-2 RNA is associated with decreased COVID-19 survival.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Das Adhikari U, Eng G, Farcasanu M, Avena LE, Choudhary MC, Triant VA, Flagg M, Schiff AE, Gomez I, Froehle LM, Diefenbach TJ, Ronsard L, Lingwood D, Lee GC, Rabi SA, Erstad D, Velmahos G, Li JZ, Hodin R, Stone JR, Honko AN, Griffiths A, Yilmaz O, Kwon DS.
PMID: 34245255
Clin Infect Dis. 2021 Jul 10; doi: 10.1093/cid/ciab623. Epub 2021 Jul 10.

The clinical significance of SARS CoV-2 RNA in stool remains uncertain. We found that extrapulmonary dissemination of infection to the gastrointestinal (GI) tract, assessed by the presence of SARS-CoV-2 RNA in stool, is associated with decreased COVID-19 survival. Measurement...

Cite
Das Adhikari U, Eng G, Farcasanu M, et al. Fecal SARS-CoV-2 RNA is associated with decreased COVID-19 survival. Clin Infect Dis. 2021;doi: 10.1093/cid/ciab623.
Das Adhikari, U., Eng, G., Farcasanu, M., Avena, L. E., Choudhary, M. C., Triant, V. A., Flagg, M., Schiff, A. E., Gomez, I., Froehle, L. M., Diefenbach, T. J., Ronsard, L., Lingwood, D., Lee, G. C., Rabi, S. A., Erstad, D., Velmahos, G., Li, J. Z., Hodin, R., Stone, J. R., Honko, A. N., Griffiths, A., Yilmaz, O., & Kwon, D. S. (2021). Fecal SARS-CoV-2 RNA is associated with decreased COVID-19 survival. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, . https://doi.org/10.1093/cid/ciab623
Das Adhikari, Upasana, et al. "Fecal SARS-CoV-2 RNA is associated with decreased COVID-19 survival." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. (2021). doi: https://doi.org/10.1093/cid/ciab623
Das Adhikari U, Eng G, Farcasanu M, Avena LE, Choudhary MC, Triant VA, Flagg M, Schiff AE, Gomez I, Froehle LM, Diefenbach TJ, Ronsard L, Lingwood D, Lee GC, Rabi SA, Erstad D, Velmahos G, Li JZ, Hodin R, Stone JR, Honko AN, Griffiths A, Yilmaz O, Kwon DS. Fecal SARS-CoV-2 RNA is associated with decreased COVID-19 survival. Clin Infect Dis. 2021 Jul 10; doi: 10.1093/cid/ciab623. Epub 2021 Jul 10. PMID: 34245255; PMCID: PMC8406863.
Copy Download .nbib Format: NLM
Photovoltages in Polycrystalline Mosaic Solar Cells.

ACS applied energy materials

Dinca SA, Schiff EA.
PMID: 34476349
ACS Appl Energy Mater. 2021 Jul 26;4(7):6711-6718. doi: 10.1021/acsaem.1c00761. Epub 2021 Jul 14.

In some thin-film solar cells the light-absorbing layer is a mosaic of crystalline grains whose boundaries run from the back to the front of the cell. We used the semiconductor modeling software Sesame to do numerical calculations of the...

Cite
Dinca SA, Schiff EA. Photovoltages in Polycrystalline Mosaic Solar Cells. ACS Appl Energy Mater. 2021;4(7):6711-6718doi: 10.1021/acsaem.1c00761.
Dinca, S. A., & Schiff, E. A. (2021). Photovoltages in Polycrystalline Mosaic Solar Cells. ACS applied energy materials, 4(7), 6711-6718. https://doi.org/10.1021/acsaem.1c00761
Dinca, S A, and Schiff, E A. "Photovoltages in Polycrystalline Mosaic Solar Cells." ACS applied energy materials vol. 4,7 (2021): 6711-6718. doi: https://doi.org/10.1021/acsaem.1c00761
Dinca SA, Schiff EA. Photovoltages in Polycrystalline Mosaic Solar Cells. ACS Appl Energy Mater. 2021 Jul 26;4(7):6711-6718. doi: 10.1021/acsaem.1c00761. Epub 2021 Jul 14. PMID: 34476349; PMCID: PMC8396803.
Copy Download .nbib Format: NLM
Showing 193 to 203 of 203 entries